Aerie Pharmaceuticals reported $29.31M in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Aerie Pharmaceuticals AERI:US $ 29.31M 2.13M
Alimera Sciences ALIM:US $ 12.15M 9.55M
Amarin AMRN:US $ 142.04M 12.45M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Cara Therapeutics CARA:US $ 20.27M 20.27M
Coherus Biosciences CHRS:US $ 82.5M 5.14M
Endo International Ordinary Shares ENDP:US $ 772.03M 58.2M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Horizon Pharma HZNP:US $ 1036.99M 204.44M
Insmed INSM:US $ 46.76M 1.39M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Merk MRK:US $ 13154M 1752M
Mirati Therapeutics MRTX:US $ 71.79M 71.79M
Novartis NOVN:VX SF 13367M 73M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Revance Therapeutics RVNC:US $ 19.74M 0.94M
Supernus Pharmaceuticals SUPN:US $ 148.46M 7.14M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M
Valeant Pharmaceuticals VRX:CN $ 2111M 11M
Zoetis ZTS:US $ 1990M 42M
Zogenix ZGNX:US $ 22.61M 3.82M